Conjuntivitis folicular por Chlamydia trachomatis: Frecuencia y pruebas diagnósticas / Follicular conjunctivitis caused by Chlamydia trachomatis: Frequency and diagnosis test

La Chlamydia trachomatis es la principal causa infecciosa de ceguera en el mundo, que empieza como conjuntivitis folicular. En el Perú se han realizado pocos estudios, debido a su dificultad diagnóstica. Se realizó un estudio en 55 pacientes de 18 a 68 años con diagnóstico de conjuntivitis folicular atendidos en el Instituto Nacional de Oftalmología (Lima, Perú) durante los años 2005 y 2006, con el objetivo de determinar la frecuencia de infección por Chlamydia trachomatis y evaluar la utilidad de la tinción de Giemsa y la inmunofluorescencia directa (IFD) para el diagnóstico de C. trachomatis en relación con el cultivo celular. La frecuencia de C. trachomatis en muestras de secreciones de conjuntivitis folicular fue de 13 por ciento (7/55) por cultivo celular, 20 por ciento (11/55) por IFD y de 9 por ciento (5/55) por Giemsa; los signos y síntomas más frecuentes fueron la presencia de secreciones y fotofobia. Todos los casos fueron varones y manifestaron no tener antecendentes de infecciones de transmisión sexual previas. Se encontró una sensibilidad de 42,9 y 85,7 por ciento y una especificidad de 98,8 y 89,6 por ciento para la tinción Giemsa e IFD respectivamente.

Chlamydia trachomatis is the principal infectious cause of blindness in the world, which begins as follicular conjunctivitis. In Peru few studies was realized by its difficulty to diagnose. A study was conducted in 55 patients 18 to 68 years with follicular conjunctivitis treated at the Instituto Nacional de Oftalmología (Lima, Peru) during the years 2005 and 2006, with the objective of determining the prevalence of Chlamydia trachomatis and evaluated the usefulness of Giemsa and direct immunofluorescence (DIF) for the diagnosis of C. trachomatis in relation to cell culture. The frequency of C. trachomatis in samples of eyes secretions was 13 per cent (7/55) for cell culture, 20 per cent (11/55) for DIF and 9 per cent (5/55) for Giemsa; the signs and symptoms more frequents were the presence of secretions and photophobia. All cases were males and reported not having had prior sexually transmitted infections. We found a sensitivity of 42,9 and 85,7 per cent, and a specificity of 98,8 and 89,6 per cent for Giemsa and DIF respectively.

Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals.

Components of biological variation can be used to assess the usefulness of reference values, to evaluate the significance of changes in serial results from an individual and to define objective analytical goals. The aim of the study was to assess, in 15 healthy subjects studied at regular monthly intervals over a period of 6 consecutive months, the biological variation of interleukin-1beta (IL-1beta), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha). Biological variation data (within-subject and between-subject coefficient of variation (CV)) were determined using a simple nested analysis of variance. Derived parameters (index of individuality, reliability coefficient and critical diferences) were calculated from within-subject and between-subject CV. The mean and standard deviation (SD), within-subject CV, between-subject CV, index of individuality and reliability coefficient were as follows: for IL-1beta, 0.67 (0.32) pg/ml, 30%, 36%, 0.85, and 0.76; for IL-8, 3.68 (1.45) pg/ml, 24%, 31%, 0.85 and 0.75; and for TNF-alpha, 3.14 (1.87) pg/ml, 43%, 29%, 1.56 and 0.50, respectively. We conclude that between-subject variation and within-subject variation are quite similar for IL-1beta and IL-8 and are relatively high for the three cytokines studied. Index of individuality is less than 1.4 for IL-1beta and IL-8, and thus reference intervals based on population studies are of limited value. On the contrary, the index of individuality for TNF-alpha is greater than 1.4 and reference values can be used for diagnosis. Quality goals for imprecision are easily achieved for the three cytokines with current methodology.

Aspartate aminotransferase in ejaculates of Manchego and Merino rams after minimal and maximal sperm damage.

Semen from Manchega and Merina breed rams was subjected to minimal and maximal sperm cell damage treatments. Seminal plasma samples were then analyzed for aspartate aminotransferase (AAT) activity. There were significant (P < 0.01) increases in enzymatic activity after maximal damage treatment in both breeds. Mean values of AAT activity were different between months (P < 0.01) and individual rams (P < 0.01). Breed significantly (P < 0.01) affected AAT activity after minimal and maximal sperm damage. There was an interaction (P < 0.01) between the 2 factors of ram and month in both breeds, but there was no interaction between breed and treatment.